文献速递神经肿瘤

18F-DOPA PET联合MRI灌注加权成像改善高级别胶质瘤亚区勾画:活检对照研究

Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study.
PubMed 文献 · J Neurooncol · 2021-10-22

结果显示联合18F-DOPA PET/MRI勾画的高级别体积更大且重叠度低,在逐活检分析中检测高级别亚区的准确率显著高于单独增强MRI。

要点

  • 18F-DOPA PET联合MRI可扩大高级别胶质瘤亚区勾画体积。
  • 联合成像检测高级别亚区准确率58%,高于单独增强MRI的42%(p=0.03)。
  • 联合18F-DOPA与先进MRI可能改善新诊断胶质瘤的治疗计划。

核心结论

  • 将18F-DOPA PET加入多模态MRI(增强和灌注加权成像)可扩大勾画体积并提高检测高级别亚区的总体准确率。

主要发现

  • 联合18F-DOPA PET/MRI勾画的高级别体积中位1.7 mL(IQR 0.0, 19.1),大于单独多模态MRI的中位1.3 mL(IQR 0.0, 12.8),重叠度低(中位Dice系数0.24,IQR 0.08, 0.59)。
  • 5例(31%)患者勾画体积显著增加。
  • 逐活检分析中,联合18F-DOPA PET/MRI检测高级别亚区准确率58%,单独增强MRI为42%(p=0.03),多模态MRI(增强+灌注)为50%(p=0.25)。

关键数值与推荐

  • 联合18F-DOPA PET/MRI检测高级别亚区准确率58%,单独增强MRI为42%(p=0.03),多模态MRI(增强+灌注)为50%(p=0.25)。

临床怎么用

  • 对新诊断胶质瘤,联合18F-DOPA PET与先进MRI可能改善治疗计划中的高级别亚区勾画。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We aimed to compare spatial extent of high-grade subregions detected with combined [18F]-dihydroxyphenylalanine (18F-DOPA) PET and MRI to the one provided by advanced multimodal MRI alone including Contrast-enhanced (CE) and Perfusion weighted imaging (PWI). Then, we compared the accuracy between imaging modalities, in a per biopsy analysis. METHODS: Participants with suspected diffuse glioma were prospectively included between June 2018 and September 2019. Volumes of high-grade subregions were delineated respectively on 18F-DOPA PET and MRI (CE and PWI). Up to three per-surgical neuronavigation-guided biopsies were performed per patient. RESULTS: Thirty-eight biopsy samples from sixteen participants were analyzed. Six participants (38%) had grade IV IDH wild-type glioblastoma, six (38%) had grade III IDH-mutated astrocytoma and four (24%) had grade II IDH-mutated gliomas. Three patients had intratumoral heterogeneity with coexisting high- and low-grade tumor subregions. High-grade volumes determined with combined 18F-DOPA PET/MRI (median of 1.7 [interquartile range (IQR) 0.0, 19.1] mL) were larger than with multimodal MRI alone (median 1.3 [IQR 0.0, 12.8] mL) with low overlap (median Dice's coefficient 0.24 [IQR 0.08, 0.59]). Delineation volumes were substantially increased in five (31%) patients. In a per biopsy analysis, combined 18F-DOPA PET/MRI detected high-grade subregions with an accuracy of 58% compared to 42% (p = 0.03) with CE MRI alone and 50% (p = 0.25) using multimodal MRI (CE + PWI). CONCLUSIONS: The addition of 18F-DOPA PET to multimodal MRI (CE and PWI) enlarged the delineation volumes and enhanced overall accuracy for detection of high-grade subregions. Thus, combining 18F-DOPA with advanced MRI may improve treatment planning in newly diagnosed gliomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Girard A, Le Reste PJ, Metais A, et al. Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study. J Neurooncol. 2021. PMID: 34686993. doi:10.1007/s11060-021-03873-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。